PEN241220P400000
- 0.00
- 0.000.00%
Penumbra Newsroom
RBC Capital Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285
10 Health Care Stocks With Whale Alerts In Today's Session
Penumbra Is Maintained at Buy by Truist Securities
Truist Financial Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $285
Express News | Penumbra Inc : RBC Raises Target Price to $285 From $232
Penumbra Is Poised For Growth As Blood Clot Awareness Rises: Analyst
Oppenheimer Maintains Penumbra(PEN.US) With Buy Rating, Maintains Target Price $275
This Elastic Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Penumbra Initiated at Outperform by Oppenheimer
Oppenheimer Initiates Penumbra(PEN.US) With Buy Rating, Announces Target Price $275
3 Medical Instruments Industry Stocks to Buy on the GenAI Wave
Price Over Earnings Overview: Penumbra
12 Analysts Assess Penumbra: What You Need To Know
Citi Maintains Penumbra(PEN.US) With Hold Rating, Raises Target Price to $245
Express News | Penumbra, Inc. : Wells Fargo Raises to Overweight From Equal Weight
Wells Fargo Maintains Penumbra(PEN.US) With Buy Rating, Cuts Target Price to $275
Positive Outlook for Penumbra: Buy Rating Driven by THUNDER Trial Success and Market Growth Prospects
Penumbra Is Maintained at Buy by Canaccord Genuity
CCORF Maintains Penumbra(PEN.US) With Buy Rating, Raises Target Price to $323
Express News | Penumbra Inc : Canaccord Genuity Raises Target Price to $323 From $260